Lindsay Androski, JD, MBA, CFA
Board Member
Arbutus Biopharma Corp (ABUS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lindsay Androski, JD, MBA, CFA
Lindsay Androski, JD, MBA, CFA is recorded as Board Member at Arbutus Biopharma Corp (ABUS). Arbutus Biopharma Corp reported in an 8-K filed May 27, 2026 that Lindsay Androski, JD, MBA, CFA was appointed director, effective May 26, 2026.
“(1) elected each of the Company’s nominees for director”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arbutus Biopharma Corp
Other people whose current roles at this company are on record from its filings.
- Lindsay Androski CEO, Chairman, Board Member
- Mark J. Murray CEO
- Michael J. McElhaugh CEO, COO, Board Member
- Tuan Nguyen CFO
- Michael McElhaugh COO
- Mike McElhaugh COO
- J. Christopher Naftzger General Counsel
- Anuj Hasija Board Member
- Eric Venker, M.D., Pharm.D. Board Member
- Frank Torti, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.